The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Glucocorticoid use, other associated factors, and the risk of tuberculosis
Abstract
Objective: To evaluate the association of glucocorticoids and other purported risk factors with the development of tuberculosis. Methods: We conducted a case‐control study of tuberculosis cases identified during 1990–2001 using the General Practice Research Database in the United Kingdom. Cases were patients with a first time diagnosis of tuberculosis accompanied by at least 6 months of treatment with at least 3 different tuberculosis medications. Up to 4 controls were matched to each case on age, sex, the practice attended by the case, index date, and amount of prior computerized records. Results: The study encompassed 497 new cases of tuberculosis and 1,966 controls derived from 16,629,041 person‐years at risk (n = 2,757,084 persons). The adjusted odds ratio (OR) of tuberculosis for current use of a glucocorticoid compared with no use was 4.9 (95% confidence interval [95% CI] 2.9–8.3). The adjusted ORs for use of <15 mg and ≥15 mg of prednisone or its equivalent daily dose were 2.8 (95% CI 1.0–7.9) and 7.7 (95% CI 2.8–21.4), respectively. Adjusted ORs of tuberculosis were 2.8 for patients with a body mass index (BMI) <20 compared with normal BMI; 1.6 for current smokers compared with nonsmokers; and 3.8, 3.2, 2.0, and 1.4 for those with history of diabetes, emphysema, bronchitis, and asthma, respectively, compared with those without such history (all P values <0.05). Conclusion: These results indicate that patients treated with glucocorticoids have an increased risk of developing tuberculosis, independent of other risk factors. Low adiposity, diabetes, current smoking, and obstructive pulmonary disorders are also important independent risk factors for tuberculosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Environment and Disease: Association or Causation?
Hill, A. B. (1965) · Proceedings of the Royal Society of Medicine · doi:10.1177/003591576505800503 · Cited by 6,974
Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agent
Keane, J., Gershon, S., Wise, R. P., Mirabile-Levens, E., Kasznica, J., Schwieterman, W. D., Siegel, J. N., & Braun, M. M. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011110 · Cited by 3,710
(2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.supplement_3.ats600 · Cited by 1,241
Glucocorticosteroid Therapy: Mechanisms of Action and Clinical Considerations
FAUCI, A. S., DALE, D. C., & BALOW, J. E. (1976) · Annals of Internal Medicine · doi:10.7326/0003-4819-84-3-304 · Cited by 1,044
Gómez‐Reino, J. J., Carmona, L., Valverde, V. R., Mola, E. M., & Montero, M. D. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11137 · Cited by 1,013
Jick, H., Jick, S. S., & Derby, L. E. (1991) · BMJ · doi:10.1136/bmj.302.6779.766 · Cited by 839
Self-citationValidity of the General Practice Research Database
Jick, S. S., Kaye, J. A., Vasilakis‐Scaramozza, C., Rodríguez, L. A. G., Ruigómez, A., Meier, C. R., Schlienger, R. G., Black, C., & Jick, H. (2003) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.23.5.686.32205 · Cited by 584
Self-citationGajalakshmi, V., Peto, R., Kanaka, T. S., & Jha, P. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14109-8 · Cited by 481
Tuberculosis infection in patients with rheumatoid arthritis and the effect of infliximab therapy
Wolfe, F., Michaud, K., Anderson, J., & Urbansky, K. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20009 · Cited by 431
T Cell Response to Mycobacterium tuberculosis
Orme, I. M., Andersen, P., & Boom, W. H. (1993) · Journal of Infectious Diseases · doi:10.1093/infdis/167.6.1481 · Cited by 423
Cited by
Jeon, C. Y., & Murray, M. B. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050152 · Cited by 1,486
Tuberculosis and diabetes mellitus: convergence of two epidemics
Dooley, K. E., & Chaisson, R. E. (2009) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70282-8 · Cited by 932
Gabriel, S. E., & Michaud, K. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2669 · Cited by 891
Latent Mycobacterium tuberculosis Infection
Getahun, H., Matteelli, A., Chaisson, R. E., & Raviglione, M. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1405427 · Cited by 775
Tobacco Smoke, Indoor Air Pollution and Tuberculosis: A Systematic Review and Meta-Analysis
Lin, H.-H., Ezzati, M., & Murray, M. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040020 · Cited by 739
Using electronic health records for population health research: a review of methods and applications
Casey, J. A., Schwartz, B. S., Stewart, W. F., & Adler, N. E. (2016) · Annual Review of Public Health · doi:10.1146/annurev-publhealth-032315-021353 · Cited by 590
The immunological life cycle of tuberculosis
Ernst, J. D. (2012) · Nature Reviews Immunology · doi:10.1038/nri3259 · Cited by 577
Understanding Latent Tuberculosis: A Moving Target
Lin, P. L., & Flynn, J. L. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903856 · Cited by 488
Infection Risk and Safety of Corticosteroid Use
Youssef, J., Novosad, S. A., & Winthrop, K. L. (2016) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2015.08.004 · Cited by 459
Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis
Buch, M. H., Smolen, J. S., Betteridge, N., Breedveld, F. C., Burmester, G., Dörner, T., Ferraccioli, G., Gottenberg, J.-E., Isaacs, J., Kvien, T. K., et al. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.144998 · Cited by 453
Winthrop, K. L., McNelley, E., Kendall, B., Marshall-Olson, A., Morris, C., Cassidy, M., Saulson, A., & Hedberg, K. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201003-0503oc · Cited by 414
The epidemiology of glucocorticoid-associated adverse events
McDonough, A. K., Curtis, J. R., & Saag, K. G. (2008) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e3282f51031 · Cited by 405
Comorbidities in rheumatoid arthritis
Michaud, K., & Wolfe, F. (2007) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2007.06.002 · Cited by 400
Nontuberculous Mycobacteria Infections in Immunosuppressed Hosts
Henkle, E., & Winthrop, K. L. (2015) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2014.11.002 · Cited by 329
Latent Tuberculosis Infection in the United States
Horsburgh, C. R., & Rubin, E. J. (2011) · New England Journal of Medicine · doi:10.1056/nejmcp1005750 · Cited by 311
Association between diabetes mellitus and active tuberculosis: A systematic review and meta-analysis
Al-Rifai, R. H., Pearson, F., Critchley, J. A., & Abu-Raddad, L. J. (2017) · PLOS ONE · doi:10.1371/journal.pone.0187967 · Cited by 310
Updates on the risk factors for latent tuberculosis reactivation and their managements
Ai, J.-W., Ruan, Q.-L., Liu, Q.-H., & Zhang, W.-H. (2016) · Emerging Microbes & Infections · doi:10.1038/emi.2016.10 · Cited by 298
Advancing host-directed therapy for tuberculosis
Wallis, R. S., & Hafner, R. (2015) · Nature Reviews Immunology · doi:10.1038/nri3813 · Cited by 291
Greenberg, J. D., Reed, G., Kremer, J. M., Tindall, E., Kavanaugh, A., Zheng, C., Bishai, W., & Hochberg, M. C. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.089276 · Cited by 275
Tuberculosis contact investigation in low prevalence countries: a European consensus
Erkens, C. G. M., Kamphorst, M., Abubakar, I., Bothamley, G. H., Chemtob, D., Haas, W., Migliori, G. B., Rieder, H. L., Zellweger, J.-P., & Lange, C. (2010) · European Respiratory Journal · doi:10.1183/09031936.00201609 · Cited by 272
Latent tuberculosis infection: An overview
Kiazyk, S., & Ball, T. (2017) · Canada Communicable Disease Report · doi:10.14745/ccdr.v43i34a01 · Cited by 266
Incidence and US Costs of Corticosteroid-Associated Adverse Events: A Systematic Literature Review
Sarnes, E., Crofford, L., Watson, M., Dennis, G., Kan, H., & Bass, D. (2011) · Clinical Therapeutics · doi:10.1016/j.clinthera.2011.09.009 · Cited by 258
Impact of Diabetes Mellitus on Treatment Outcomes of Patients with Active Tuberculosis
Dooley, K. E., Tang, T., Golub, J. E., Dorman, S. E., & Cronin, W. (2009) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2009.80.634 · Cited by 256
Corticosteroid-Induced Adverse Events in Adults: Frequency, Screening and Prevention
Fardet, L., Kassar, A., Cabane, J., & Flahault, A. (2007) · Drug Safety · doi:10.2165/00002018-200730100-00005 · Cited by 254
Indoor air pollution and the lung in low- and medium-income countries
Kurmi, O. P., Lam, K. B. H., & Ayres, J. G. (2012) · European Respiratory Journal · doi:10.1183/09031936.00190211 · Cited by 196
Does tuberculosis threaten our ageing populations?
Byng-Maddick, R., & Noursadeghi, M. (2016) · BMC Infectious Diseases · doi:10.1186/s12879-016-1451-0 · Cited by 149
Glucocorticoids: Complications to Anticipate and Prevent
Gensler, L. S. (2013) · The Neurohospitalist · doi:10.1177/1941874412458678 · Cited by 100
Lee, C.-H., Jeong, Y.-J., Heo, E. Y., Park, J. S., Lee, J. S., Lee, B. J., Park, Y. S., Song, E. H., Yang, Y. J., Cho, Y. S., et al. (2013) · BMC Public Health · doi:10.1186/1471-2458-13-720 · Cited by 38
Metadata
- Authors
- Jick, S. S., Lieberman, E. S., Rahman, M. U., & Choi, H. K.
- Venue
- Arthritis Care & Research
- Publisher
- Wiley
- Published
- 2006-02-06
- Volume
- 55
- Issue
- 1
- Pages
- 19-26
- ISSN
- 0893-7524 (ISSN-L)
- 1529-0123
- OpenAlex
- W2002815339
- Cited by
- 477
- References
- 19
- FWCI
- 7.84
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.